Home Public Notice Voluntary Recall Of Specified Batches Of Medicines Manufactured By Remedica Limited

Voluntary Recall Of Specified Batches Of Medicines Manufactured By Remedica Limited

Voluntary Recall Of Specified Batches Of Medicines Manufactured By Remedica Limited

The Botswana Medicines Regulatory Authority (BOMRA) wishes to inform the public and stakeholders of a voluntary recall received from Remedica Limited through Pharm Vision (Pty) Ltd concerning specified batches of the eight (8) products listed below.

What members of the public should do?

Members of the public who are in possession of any of the below-mentioned affected batches of the products are advised to:

  • Stop using the affected batch (es) products immediately;
  • Return the affected product(s) to the pharmacy or other point of purchase from which they were obtained and follow the instructions provided by the supplier regarding its return or replacement.
  • Seek advice from a healthcare professional regarding continued treatment where applicable.
  • Patients who have used any of the affected batches and experience suspected adverse effects are encouraged to seek medical attention and report the suspected adverse drug reaction to BOMRA

The recall is limited to the specific batches identified in the table below:

Registration NumberProductGeneric NamePack SizeBatch NumberExpiry Date
BOT9800128Bralix Capsule 5mg/2.5mgChlordiazepoxide and Clidinium 5mg/2.5mg3097921
109041
100250
11/2026
04/2028
02/2027
BOT9800133Carbimazole tablets 5MGCarbimazole100119012
121187
125422
125423
01/08/2026
01/12/2026
01/07/2027
01/07/2027
BOT1402581A/BClonotril tablets 2mgClonazepam30103409
103410
111387
118362
127305
June 2027
June 2027
July 2028
July 2029
November 2030
BOT0100453Cloxacillin Capsules 250mgCloxacillin100122368
127170
March 2028
December 2028
BOT0100454Credanil 100mg/25mgLevodopa/Carbidopa100104433
110135
120579
120580
126187
126935
126936
09/2027
06/2028
11/2029
11/2029
10/2030
11/2030
11/2030
BOT1803407Remathen 100mgRemathen Prolonged release100107963
122606
111947
March 2028
March 2030
September 2028
BOT 302366Gabapentin (Gabenil) 100mg Hard Capsules (pack of 100).Gabenil 100mg100114755
126777
26/01/2027
10/11/2028
BOT0801109Griseofulvin 500mg tablets (pack of 100’s).Griseofulvin 500mg100110026
104383
12/06/2028
22/09/2027

Reporting of adverse drug reactions

Healthcare professionals and members of the public are encouraged to report any suspected adverse drug reactions to BOMRA.

Reports may be submitted through the available adverse drug reaction reporting platforms, including:

Full Document:

Most vaccines are safe and well tolerated. However, if you experience any discomfort after vaccination, seek immediate medical attention and ask your healthcare provider to report the event to BoMRA